Related terms
- Sham
- An inactive version of a treatment designed to look and feel real, such as a device that lights up but delivers almost no energy. It lets researchers separate the effect of the light from the effect of expectation.
- Blinding
- Keeping people unaware of who receives the real treatment and who receives the sham. In a single-blind study the participants do not know. In a double-blind study the researchers who measure the results do not know either. It reduces bias.
- Placebo effect
- Benefit that comes from expecting a treatment to work rather than from the treatment itself. It can be strong in studies of pain and mood, which is why sham-controlled trials matter.
Research that mentions sham device
7 studies in our archive have this term in the title. The newest are below.
Randomized, double-blind, sham-controlled trial of an intraoral photobiomodulation device for oral mucositis and associated complications due to radiotherapy for head and neck cancer
Daily intraoral PBM therapy using an LED-based device was safe, well tolerated, and significantly reduced the incidence of severe OM and associated complications in HNC patients undergoing IMRT with or without concurrent chemotherapy.
Photobiomodulation therapy with an 830-nm light-emitting diode for the prevention of thyroidectomy scars: a randomized, double-blind, sham device-controlled clinical trial
Improvements in color variation, height, pigmentation, and vascularity at 6 months were greater in the treatment group than in the control group, although the differences were not significant.
Low-level light therapy using a helmet-type device for the treatment of androgenetic alopecia: A 16-week, multicenter, randomized, double-blind, sham device-controlled trial
LLLT showed a significant effect on increasing hair density in patients with androgenetic alopecia. LLLT could be a safe and effective treatment for androgenetic alopecia in both sexes.
Low-level laser therapy for the treatment of androgenetic alopecia in Thai men and women: a 24-week, randomized, double-blind, sham device-controlled trial
However, the limitations of this study are small sample size, no long-term follow-up data, and use of inappropriate sham devices, which do not reflect the true negative control.
Efficacy and Safety of a Low-Level Light Therapy for Androgenetic Alopecia: A 24-Week, Randomized, Double-Blind, Self-Comparison, Sham Device-Controlled Trial
The use of LLLT might be an effective, safe, well-tolerated treatment for AGA.
Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study
We observed a statistically significant difference in the increase in terminal hair density between lasercomb- and sham-treated subjects. No serious adverse events were reported.
Read this with care
- This entry is general information, not medical advice. See the disclaimer.
- Definitions are written for readers new to the field and may be simplified. Check the full paper when it matters.
- Found a mistake? Tell us.